Skip to main content
. 2022 Mar 1;2(2):100125. doi: 10.1016/j.xops.2022.100125

Table 8.

Number of Anti-VEGF Injections in Different Copayment Proportion Groups

Age
≥75 Yrs
70–74 Yrs
Copayment proportion 30% 10% P Value 30% 20% P Value
Newly treated AMD patients 10 463 104 717 - 4947 37 633 -
Anti-VEGF injection numbers in the first 1 yr (mean ± SD) 3.94 ± 2.37 3.74 ± 2.29 <0.0001 3.98 ± 2.37 3.83 ± 2.35 0.0003
Anti-VEGF Injection Numbers in 3 yrs (mean ± SD) 6.95 ± 5.95 6.37 ± 5.64 <0.0001 7.45 ± 6.40 6.94 ± 5.98 0.0003

AMD = age-related macular degeneration; SD = standard deviation; VEGF = vascular endothelial growth factor.

The basic copayment is 30%. If the annual income is <33 700 000 Japanese Yen, copayment is reduced to 10% and 20% for individuals aged ≥75 and 70–74 years, respectively.